News & Media

Access press releases, presentations, and corporate information.

Press Room

News Releases

05/02/23

Neurocrine Biosciences to Present at the Bank of America Securities 2023 Healthcare Conference

05/01/23

Neurocrine Biosciences Supports the Mental Health Community During Tardive Dyskinesia Awareness Week

04/12/23

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2023 Financial Results

03/21/23

Neurocrine Biosciences to Present at the Stifel 2023 CNS Days

03/09/23

Neurocrine Biosciences Announces Results from the Real-World RE-KINECT™ Study Published in the Journal of Patient-Reported Outcomes Demonstrating the Effects of Possible Tardive Dyskinesia (TD) on Patient Health and Social Functioning

03/09/23

Neurocrine Biosciences Presents Data on In Vitro Dissolution Performance of INGREZZA® (valbenazine) Capsule Contents via Soft Foods or Feeding Tube at AMDA - PALTC 2023 Annual Conference

03/08/23

Neurocrine Biosciences to Participate at Investor Conferences in March

Resources

About Neurocrine Biosciences

Learn About Us and Our Work

Clinical Studies

Check Out What We’re Studying

Pipeline

Check Out What We’re Working On